Online citations, reference lists, and bibliographies.
← Back to Search

Malignant Pleural Mesothelioma: Evaluation With CT, MR Imaging, And PET.

Z. Wang, G. Reddy, M. Gotway, C. Higgins, D. Jablons, M. Ramaswamy, R. Hawkins, W. Webb
Published 2004 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Imaging plays an essential role in the evaluation of malignant pleural mesothelioma (MPM). Computed tomography is the primary imaging modality used for the diagnosis and staging of MPM. Magnetic resonance (MR) imaging and, more recently, positron emission tomography (PET) have emerged as modalities that can provide additional important diagnostic and prognostic information to help further delineate the extent of disease, especially in surgical candidates. Use of MR imaging performed with different pulse sequences and gadolinium-based contrast material can improve the detection of tumor extension, especially to the chest wall and diaphragm. PET can provide both anatomic and metabolic information, especially in cases of extrathoracic and mediastinal nodal metastasis. Each imaging modality has its advantages and limitations, but their combined use is crucial in determining the most appropriate treatment options for patients with MPM.
This paper references
10.1097/00004728-199505000-00006
CT‐Guided Pleural Needle Biopsy in the Diagnosis of Malignant Mesothelioma
M. Metintas (1995)
10.2214/AJR.155.5.2120965
Malignant pleural mesothelioma: CT manifestations in 50 cases.
A. Kawashima (1990)
10.1016/S0022-5223(19)36577-8
The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial.
V. Rusch (1991)
10.1016/0169-5002(94)00404-B
Evaluation of the clinical TNM staging system for malignant pleural mesothelioma: an assessment in 88 patients.
L. Tammilehto (1995)
10.1378/CHEST.108.4.1122
A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.
V. Rusch (1995)
10.1016/0899-7071(94)00059-L
Multiplanar display of spiral CT data of the pulmonary hila in patients with lung cancer. Preliminary observations.
A. Padhani (1995)
10.1378/CHEST.93.2.443B
Extrathoracic lymph node metastases in malignant pleural mesothelioma.
M. Huncharek (1988)
10.1016/S0022-5223(99)70469-1
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
10.1148/RADIOGRAPHICS.18.5.9747607
Imaging of mediastinal lymph nodes: CT, MR, and FDG PET.
P. Boiselle (1998)
10.2214/AJR.172.4.10587144
Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.
R. Heelan (1999)
Prognostic value of FDG PET imaging in malignant pleural mesothelioma.
D. C. Ng (2000)
10.2214/AJR.166.2.8553940
The proposed new international TNM staging system for malignant pleural mesothelioma: application to imaging.
E. Patz (1996)
10.1067/MTC.2002.125817
Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma.
T. T. Lee (2002)
10.1378/CHEST.107.6_SUPPLEMENT.332S
Current approach to malignant mesothelioma of the pleura.
J. Aisner (1995)
10.5694/j.1326-5377.1991.tb121175.x
Pleurectomy for mesothelioma
R. Brancatisano (1991)
10.1148/RADIOGRAPHICS.16.3.8897628
From the archives of the AFIP. Malignant pleural mesothelioma: radiologic-pathologic correlation.
B. H. Miller (1996)
10.1016/S0936-6555(05)80582-5
The role of palliative radiotherapy in malignant mesothelioma.
D. Bissett (1991)
Prognostic value of FDG PET imaging in malignant pleural mesothelioma.
F. Bénard (1999)
10.1016/S0022-5223(19)35312-7
The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma.
V. Rusch (1988)
Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.
H. Zhuang (2001)
10.1067/MTC.2000.106529
Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma.
D. Schneider (2000)
10.1093/OXFORDJOURNALS.AJE.A009093
Analysis of current trends in United States mesothelioma incidence.
B. Price (1997)
10.1002/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO;2-V
Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 1: Diagnosis
C. Boutin (1993)
10.1148/RADIOGRAPHICS.22.2.G02MR08387
From the archives of the AFIP. Benign tumors and tumorlike lesions of the gallbladder and extrahepatic bile ducts: radiologic-pathologic correlation. Armed Forces Institute of Pathology.
A. D. Levy (2002)
10.1002/DC.2840090106
Cytopathology of malignant mesothelioma: A study of its patterns and histological bases
L. Dibonito (1993)
10.1378/CHEST.114.3.713
Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography.
F. Bénard (1998)
10.1200/JCO.1993.11.8.1559
Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.
A. Chahinian (1993)
10.2214/AJR.154.3.2106209
CT in differential diagnosis of diffuse pleural disease.
A. Leung (1990)
10.2214/AJR.159.5.1414807
Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.
E. Patz (1992)



This paper is referenced by
10.3390/cancers12051186
Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge
D. M. Abbott (2020)
10.3348/JKSR.2019.0165
흉막의 여러 가지 양성 및 악성 종양 혹은 종양 같은 질환들의 영상 소견: 임상 화보
배 준영 (2020)
10.1007/s11307-009-0203-6
Prognostic Value of 18F-FDG PET/CT in Patients with Malignant Pleural Mesothelioma
S. Lee (2009)
10.1200/JCO.2008.19.8523
Malignant pleural mesothelioma.
A. Tsao (2009)
Orphanet Journal of Rare Diseases Malignant Mesothelioma Disease Name and Definition Epidemiology and Aetiology
Alastair J. Moore ()
10.1007/978-88-470-5752-4_13
Diseases of the Chest Wall, Pleura, and Diaphragm
A. Kelly (2015)
10.1016/j.rx.2010.02.009
[Solution to case 26. Malignant pleural mesothelioma].
E Barcina García (2011)
Zahlen und Fakten zum Pleuramesotheliom im 21. Jahrhundert: Epidemiologie, Diagnostik, Therapie // Numbers and facts regarding the malignant pleural mesothelioma in the 21st century: epidemiology, diagnostics, therapy
Watzka Sb (2019)
10.1177/0300891618765538
On the diagnosis of malignant pleural mesothelioma: A necropsy-based study of 171 cases (1997–2016)
P. Barbieri (2018)
10.1007/s11307-010-0426-6
Current Evidence Base of FDG-PET/CT Imaging in the Clinical Management of Malignant Pleural Mesothelioma: Emerging Significance of Image Segmentation and Global Disease Assessment
S. Basu (2010)
10.25748/ARP.10545
Pleural sarcomatoid mesothelioma: a rare type of malignant mesothelioma
P. Leitão (2017)
10.1016/B978-343723045-5.10010-3
KAPITEL 10 – Pleuramesotheliom
Hedvig Hricak (2009)
10.1016/B978-1-4557-3383-5.00082-8
82 – Pleural Tumors
V. Broaddus (2016)
10.1016/j.jtho.2019.08.012
Radiologic Considerations And Standardization Of Malignant Pleural Mesothelioma (MPM) Imaging Within Clinical Trials: Consensus Statement From The NCI Thoracic Malignancy Steering Committee - International Association For The Study Of Lung Cancer - Mesothelioma Applied Research Foundation Clinical T
R. Gill (2019)
10.1016/j.lungcan.2018.11.033
Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group.
S. Armato (2019)
10.1007/978-3-642-38351-9_9
Diagnostic Thoracoscopy: Malignant Pleural Effusion
M. Froudarakis (2014)
10.1016/J.LUNGCAN.2007.09.027
Current state and future directions of pleural mesothelioma imaging.
S. Armato (2008)
10.5795/JJSCC.50.115
肺野に孤立性陰影を認めた悪性胸膜中皮腫の 1 例
栄作 宮内 (2011)
10.1136/bmjopen-2012-001620
Utilisation of a thoracic oncology database to capture radiological and pathological images for evaluation of response to chemotherapy in patients with malignant pleural mesothelioma
George B. Carey (2012)
10.3727/036012906815844256
Reduced glucose uptake with markedly increased gastrin releasing peptide, osteopontine & asbestos found in dark black areas of PET Scan of chest wall in patient with mesothelioma.
Y. Ōmura (2006)
10.1097/RLU.0b013e3182175631
An unusual unilocular mesothelial cyst of the pleura: a case report.
Y. Monzen (2011)
Tumors of the chest wall and pleura; a pictorial review
A. E. Mas (2014)
10.5114/kitp.2017.72232
Malignant mesothelioma as a difficult interdisciplinary problem
W. Rokicki (2017)
10.1007/1-84628-187-3_7
PET and PET/CT Imaging in Lung Cancer
P. Rigo (2006)
10.1016/j.arbres.2014.06.005
Diagnosis and treatment of malignant pleural mesothelioma.
F. Rodríguez Panadero (2015)
10.1016/J.EJCDT.2014.09.001
The use of multi-detector computed tomography and ultrasonography for evaluation of pleural lesions
A. Bediwy (2015)
10.1016/j.jtho.2019.08.2506
EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach.
A. Nicholson (2019)
10.1007/978-3-030-27233-3_8
Primary Tumors of the Pleura
R. Ledda (2020)
10.26650/iuitfd.2019.0019
MALIGN PLEVRAL MEZOTELYOMA AYIRICI TANISI VE PROGNOZUNDA 18F-FDG PET/BT’NİN ROLÜ
D. Şimşek (2019)
10.1148/rg.283075082
Neoplastic and nonneoplastic conditions of serosal membrane origin: CT findings.
Y. J. Jeong (2008)
10.1016/j.remn.2011.06.002
The role of FDG PET-CT in differential diagnosis of pleural pathologies.
U. Elboğa (2012)
Characterization of malignant pleural mesothelioma : possibilities for an individualized therapeutic arsenal
Adam Szulkin (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar